Georgia vs Ireland: HIV/AIDS deaths averted by antiretroviral therapy
Georgia
391.52 deaths
in 2024
Ireland
333.89 deaths
in 2024
Georgia rank
97th
Ireland rank
99th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Georgia
- Ireland
How they compare
Georgia currently reports 391.52 deaths against 333.89 deaths in Ireland, a difference of 57.63 deaths.
That makes Georgia's figure about 1.2 times Ireland's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Ireland ahead.
Georgia ranks 97th and Ireland ranks 99th of 157 countries.
Across the 4 decades both report, Georgia averaged higher in 1 and Ireland in 3.
Head to head by decade
| Decade | Georgia | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 20.43 deaths | 20.43 deaths | Ireland |
| 2000s | 21.22 deaths | 143.29 deaths | 122.07 deaths | Ireland |
| 2010s | 188.92 deaths | 229.99 deaths | 41.06 deaths | Ireland |
| 2020s | 359.78 deaths | 282.18 deaths | 77.61 deaths | Georgia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Georgia or Ireland?
- Georgia, at 391.52 deaths against 333.89 deaths in Ireland as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Georgia and Ireland?
- 57.63 deaths, with Georgia ahead.
- How many years of comparable data are there for Georgia and Ireland?
- 35 years are reported by both, from 1990 to 2024.
- How do Georgia and Ireland rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Georgia ranks 97th and Ireland ranks 99th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.